The REAL-PE analysis is the largest real-world and near real-time dataset evaluating advanced therapies for PE patients.
The results? Patients treated with the EKOS™ System had statistically significant lower rates of major bleeding and intracerebral haemorrhage than patients treated with Inari Medical’s™ FlowTriever™ system. In fact, all studied safety events trended in favor of the EKOS system, as did 30-day all-cause readmission rates.1
Hear from lead author Dr. Peter Monteleone, as he discusses the REAL-PE analysis
In comparison to patients who were treated with the FlowTriever System, patients treated with the EKOS system had a statistically significant:
![Target thrombus safely Icon of blood drop](/en-EU/medical-specialties/vascular-surgery/venous-thromboembolism-portal/whats-new/real-pe/_jcr_content/root/container/container_947831390/container_1510545751/container_1565589718_1773813933/container_copy/image_copy.coreimg.png/1697045065305/icon-major-bleeding.png)
28%
lower rate of major bleeding events*1
FlowTriever (n=118/682),
EKOS (n=195/1577), p=0.0018
(ISTH Definition)
![Superior clot dissolution Icon of brain hemorrhage](/en-EU/medical-specialties/vascular-surgery/venous-thromboembolism-portal/whats-new/real-pe/_jcr_content/root/container/container_947831390/container_1510545751/container_1565589718_1773813933/container/image_copy.coreimg.png/1694716633163/icon-brain-hemorrage.png)
77%
lower rate of intracerebral haemorrhage(0.3% incidence of ICH in patients treated with EKOS)*1
FlowTriever (n=9/682), EKOS (n=5/1577), p=0.005
![Icon of hospital](/en-EU/medical-specialties/vascular-surgery/venous-thromboembolism-portal/whats-new/real-pe/_jcr_content/root/container/container_947831390/container_1510545751/container_1565589718_1773813933/image.coreimg.png/1695676760622/icon-hospital-accent-light-w.png)
Comparable in-hospital mortality rates (p=0.167), 30-day all-cause readmission rates (p=0.777), and median lengths of hospital stay*1